Elekta receives significant order to deliver cancer care solutions to Iraq

| Source: Elekta AB
STOCKHOLM, January 24 – Elekta has received an important order from Iraq for
state-of-the-art radiation therapy equipment. The deal includes 10 Elekta
Synergy® Platform linear accelerators (linacs) to be delivered to five Iraqi
Ministry of Health sites (two linacs per site): Babil, Basrah, Karbala, Missan
and Nasriah.
The deal for each site includes treatment planning software (TPS), MOSAIQ®
Oncology Information Systems, patient fixation solutions as well as services.

The total contract is valued at more than USD 16 million and will be booked
during Elekta’s third fiscal quarter. Shipment is planned to commence in early

Elekta’s President and CEO, Tomas Puusepp, says: “It is with great pride that we
announce this order. Elekta will give Iraqi doctors the possibility to offer
their patients world class care.”

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on January 24, 2014.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,500 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker STO:EKTAB. Website: